A fourth dose of mRNA COVID-19 vaccine boosted antibodies among half of kidney transplant recipients with suboptimal immune responses after three doses, a French case series found. ...
... as daily infections break records and hospitals across the country near capacity during the Omicron surge, many people have raised questions about whether they'll need to get a fourth dose.
At-home rapid antigen tests are reselling for triple the retail price on some digital marketplaces. Testing locations in L.A. County have been overwhelmed by mile-long lines, with some events canceled due to traffic. Some would-be self-testers have resigned themselves to driving between CVS and Walgreens locations, hoping to snag a kit at a reasonable price.
Companies are racing to fulfill the excess demand.
Abbott Laboratories, which makes the BinaxNOW rapid antigen test, expects to produce 70 million tests this month and is working to raise that to 100 million, said CEO Robert Ford.
fizer CEO Albert Bourla said a vaccine that targets the omicron variant of Covid will be ready in March, and the company’s already begun manufacturing the doses.
“This vaccine will be ready in March,” Bourla told CNBC’s Squawk Box. “We (are) already starting manufacturing some of these quantities at risk.”
Recent Comments